ICPT 19 (+0%)
US45845P1084BiotechnologyBiotechnology

Intercept Pharmaceuticals (ICPT) Financial Metrics

This table shows a selected set of financial data points of Intercept Pharmaceuticals (ICPT). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2022 6.56 0 1.89 418.56M 0.41 285.71M -27.35M -61.7M 221.82M 50.52M
2021 -2.88 0 -5.65 516.98M -0.17 363.47M -42.04M -53.6M -91.43M 84.71M
2020 -8.34 0 -2.96 814.36M -0.41 312.69M -173.92M -212.2M -274.88M 58.15M
2019 -10.89 0 -11.38 3.92B -0.55 252M -237.75M -303.54M -344.68M 70.06M
2018 -10.86 0 -9.28 2.87B -0.62 179.8M -240.88M -274.14M -309.24M 43.25M
2017 -14.38 0 -4.06 1.46B -0.59 130.96M -275.79M -326.5M -360.37M 70.01M
2016 -16.74 0 -6.49 2.68B -0.59 24.95M -347.52M -394.8M -412.83M 43.68M
2015 -9.56 0 -15.63 3.54B -0.5 2.78M -168.84M -224.74M -226.43M 32.74M
2014 -13.63 0 -11.45 3.24B -1.4 1.74M -92.38M -282.78M -283.23M 20.02M
2013 -3.76 0 -18.16 1.23B -0.52 1.62M -29.64M -67.69M -67.79M 13.36M
2012 -6.95 0 -4.93 215.14M -0.66 2.45M -15.79M -43.44M -43.64M 45.51M
2011 -1.19 0 0 0 -0.7 1.81M 2.54M -12.31M -12.74M 17.71M
2010 -4.53 0 0 0 0 489K -13.69M -14.61M -15.09M 15.42M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.